Founder Directory
Built by Keitoto
Founders3
Known for these resultsRole0%Role is parsed from founder titles in yc.db. Known for 0% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company0%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 0% of these rows have at least one match.School67%School is matched from bios, case-sensitive for acronyms. 67% of these rows have at least one match.
- Burak YILMAZFounder · Kernal BiologicsS20Healthcare · Boston
- Jeff OzdemirFounder · Kernal BiologicsS20Healthcare · Boston
- Yusuf Erkul@yusuf_erkulFounder · Kernal BiologicsS20Healthcare · Boston
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Burak YILMAZKernal BiologicsFounderSummer 2020HealthcareBoston, United States20—Jeff OzdemirKernal BiologicsFounderSummer 2020HealthcareBoston, United States20—Yusuf ErkulKernal BiologicsFounderSummer 2020HealthcareBoston, United States20https://x.com/yusuf_erkulShowing 1–3 of 3 founders
Burak YILMAZ
Founder·Kernal Biologics
PRIMARY INFO
RoleFounder· not in title
Team size20
BatchSummer 2020
LocationBoston, United States
Company statusActive
StageEarly
BIO
My name is Burak Yilmaz, MS, co-founder, and lead designer of Kernal Biologics. As a synthetic biologist, I co-invented stealth and onco-selective mRNA platform technology in Kernal. Kernal is my second endeavor. Previously, I founded Sentegen/Sentebiolab which is a synthetic biology company that produces synthetic DNA for research and diagnostic purposes.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
No notable employer or school mentioned in the bio.
Credentialsnone mentioned
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
Kernal is creating mRNA 2.0 therapies that work in specific cells